D.Western Therapeutics Institute, Inc. [4576.T]
TOKYO, Apr 17 (Pulse News Wire) – D.Western Therapeutics Institute, Inc. (4576.T) resolved to issue restricted shares as compensation on April 17, 2026.
The issuance will take place on May 14, 2026, involving ordinary shares totaling 501,200. Each share will be priced at ¥94, resulting in a total issuance value of ¥47.1 million. This move follows decisions made during previous meetings held on February 15, 2018, and March 29, 2018, aimed at aligning executive interests with shareholder gains. Additionally, the resolution was approved at the company's 25th annual shareholders' meeting held on March 30, 2023.
The restricted shares will be allocated to two groups: internal employees and directors of subsidiary companies. Employees will receive their shares from May 14, 2026, to May 13, 2027, while directors will be subject to restrictions until May 13, 2029. Any untransferred shares will revert to the company upon expiration of the restriction periods or earlier under certain conditions. Further details on the allocation process, including the number of shares per individual and the rationale behind the distribution, will be determined based on contributions and overall performance considerations.
🟡 Confidence: Standard AI-translated content.